로딩 중…
지수 로딩 중…
Royalty Pharma plc
RPRX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$52.96-1.38%
2026-06-18
Price Chart
Royalty Pharma plc+51.70%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $30.50B |
| Revenue | $2.44B |
| Net Income | $828M |
| Total Assets | $19.82B |
| Net Assets | $6.89B |
| Value | |
| P/E | 36.85x |
| P/B | 4.43x |
| PEG | 1.55x |
| P/S | 12.50x |
| EV/EBITDA | 21.97x |
| FCF Yield | 8.70% |
| Profitability | |
| ROE | 12.01% |
| ROA | 4.18% |
| Op. Margin | 67.93% |
| Revenue Growth | 10.97% |
| Earnings Growth | 23.77% |
| Financial Health | |
| Debt Ratio | 143.41% |
| Total Debt | $8.96B |
| FCF | $2.65B |
| Cash | $586M |
| Current Ratio | 2.66x |
| Net Debt/EBITDA | 4.73x |
| Dividend | |
| Div. Yield | 1.27% |
| Div. Growth | 0.47% |
| Performance | |
| 1Y Return | 51.70% |
| 1M Return | 1.05% |
| From 52W High | -6.27% |
| 1Y MDD | -7.94% |
| Trading | |
| Volume | 7,309,331 shares |
| Trading Value | $386M |
| Per Share | |
| EPS | $1.79 |
| BPS | $15.00 |